NSCLC responds to hypoxic microenvironments by downregulating YTHDF1, thereby inducing cisplatin resistance through the modulation of CDK2, CDK4, and cyclin D1 translation.138. Here, YTHDF1 is linked to non-small cell lung carcinoma.